Clinical trial
Efficacy and Safety of Activase (Ateplase) vs Placebo in Complicated Pleural…
NCT00468104 · Midwest Pulmonary and Critical Care, Other · Completed
Key facts
| NCT number | NCT00468104 |
|---|---|
| Title | Efficacy and Safety of Activase (Ateplase) vs Placebo in Complicated Pleural Effusions (CPE)/Empyemas |
| Official title | Response to Instillation of Activase in the Pleural Cavity vs Placebo in the Management of Complicated Pleural Effusion/Empyema |
| Acronym | CPE |
| Lead sponsor | Midwest Pulmonary and Critical Care, Other |
| Collaborators | Genentech, Inc. Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Pleural Effusion Associated With Pulmonary Infection, Bacterial Pleural Effusion Other Than Tuberculosis |
| Intervention type | Drug |
| Interventions | Alteplase, Placebo |
| Enrollment | 100 |
| Start date | Apr 1, 2004 |
| Primary completion | Oct 1, 2008 |
| Completion | Aug 1, 2009 |
| First posted | May 2, 2007 |
| Last update posted | Apr 30, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: